GELFOS M- aluminum phosphate gel 
Boryung Pharmaceutical Co., Ltd

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Aluminium phosphate 61.9%, Magnesium hydroxide 2.0%, Simethicone 0.2%

Water, Methylparaben, Propylparaben, etc

antacid

keep out of reach of the children

Relief the symptom of hypergastric acidity (including gastritis and gastroduodenal ulcer disease), heartburn, gastric discomfort, gastric fullness, nausea, vomiting, crapulence, gastric pain, belching up a bit of sour vomit, constipation protection and degassing.

Don't place the product in any place where it will be subjected to extremely high or low temperatures or direct sunlight.

Take 1 sachet orally, 3 times daily between each meal(at the mealtime and between each meal), 4 hours between dosage.

label

GELFOS M 
aluminium phosphate, magnesium hydroxide, simethicone gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:64644-4002
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ALUMINUM PHOSPHATE (UNII: F92V3S521O) (ALUMINUM PHOSPHATE - UNII:F92V3S521O) ALUMINUM PHOSPHATE61.9 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
WATER (UNII: 059QF0KO0R)  
MAGNESIUM HYDROXIDE (UNII: NBZ3QY004S)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:64644-4002-120 g in 1 POUCH; Type 0: Not a Combination Product04/08/201604/11/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33102/28/201604/11/2016
Labeler - Boryung Pharmaceutical Co., Ltd (631099624)
Registrant - Boryung Pharmaceutical Co., Ltd (631099624)
Establishment
NameAddressID/FEIBusiness Operations
Boryung Pharmaceutical Co., Ltd631099624manufacture(64644-4002)

Revised: 4/2016
 
Boryung Pharmaceutical Co., Ltd